Yeahhh, realistically ...  If you are RVX, you gotta have a plan to do it on your own (with strategic partners), with flexible and contingency Mfg & Dist partners until somebody sees enough certainty and does the math and it appears that it is better to control and "own the works", plus potentially the epigenetics platform for the "future" ... and makes an offer you can't refuse ... 

So many ways this could go, over time ... options and competition (and BT statuses) are good. Looks like a $5b+ company shaping up at some point, hopefully, whether as an RVX (with strategic partners) listing, or as a transaction. As somebody else said, patience is a virtue.

jmho ... (still working on the patience thing)